Fang Wu

2.4k total citations · 1 hit paper
80 papers, 1.9k citations indexed

About

Fang Wu is a scholar working on Molecular Biology, Cancer Research and Biochemistry. According to data from OpenAlex, Fang Wu has authored 80 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 12 papers in Cancer Research and 10 papers in Biochemistry. Recurrent topics in Fang Wu's work include MicroRNA in disease regulation (6 papers), Sulfur Compounds in Biology (5 papers) and Amino Acid Enzymes and Metabolism (5 papers). Fang Wu is often cited by papers focused on MicroRNA in disease regulation (6 papers), Sulfur Compounds in Biology (5 papers) and Amino Acid Enzymes and Metabolism (5 papers). Fang Wu collaborates with scholars based in China, Switzerland and United States. Fang Wu's co-authors include Yingchuan Li, Wei-Feng Huang, Yongmei Cao, Jiawei Shang, Ping Feng, Qin Tan, Haijun Zhang, Jian Xiao, Xiaoping Zhang and Jing Yu and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Fang Wu

79 papers receiving 1.8k citations

Hit Papers

Inhibitor of apoptosis-stimulating protein of p53 inhibit... 2020 2026 2022 2024 2020 100 200 300 400

Peers

Fang Wu
Faisal Thayyullathil United Arab Emirates
Sunghyouk Park South Korea
James D. West United States
Fang Wu
Citations per year, relative to Fang Wu Fang Wu (= 1×) peers Anna Lisa Furfaro

Countries citing papers authored by Fang Wu

Since Specialization
Citations

This map shows the geographic impact of Fang Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fang Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fang Wu more than expected).

Fields of papers citing papers by Fang Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fang Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fang Wu. The network helps show where Fang Wu may publish in the future.

Co-authorship network of co-authors of Fang Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Fang Wu. A scholar is included among the top collaborators of Fang Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fang Wu. Fang Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gui, Weiwei, et al.. (2025). Paradoxical regulation of IGF2 in promoting lipid metabolism in adipose tissues. Communications Biology. 8(1). 1026–1026.
2.
Hu, Youtian, et al.. (2024). Cystathionine γ-lyase-derived H2S negatively regulates thymic egress via allosteric inhibition of sphingosine-1-phosphate lyase. Acta Pharmacologica Sinica. 45(11). 2366–2379. 2 indexed citations
3.
Wang, Jiafeng, et al.. (2023). Rgl-exomiR-7972, a novel plant exosomal microRNA derived from fresh Rehmanniae Radix, ameliorated lipopolysaccharide-induced acute lung injury and gut dysbiosis. Biomedicine & Pharmacotherapy. 165. 115007–115007. 57 indexed citations
4.
Guo, Fangyuan, Lianyi Wang, Mengqi Wang, et al.. (2023). Protein corona, influence on drug delivery system and its improvement strategy: A review. International Journal of Biological Macromolecules. 256(Pt 2). 128513–128513. 28 indexed citations
5.
Guo, Fangyuan, Yunlong Jiao, Mengqi Wang, et al.. (2023). Synergistic effects of multidrug/material combination deliver system for anti-mutidrug-resistant tumor. International Journal of Pharmaceutics. 649. 123669–123669. 7 indexed citations
6.
Wu, Fang, Wei-Feng Huang, Qin Tan, et al.. (2021). ZFP36L2 regulates myocardial ischemia/reperfusion injury and attenuates mitochondrial fusion and fission by LncRNA PVT1. Cell Death and Disease. 12(6). 614–614. 35 indexed citations
7.
Cao, Yongmei, Wei-Feng Huang, Fang Wu, et al.. (2021). ZFP36 protects lungs from intestinal I/R-induced injury and fibrosis through the CREBBP/p53/p21/Bax pathway. Cell Death and Disease. 12(7). 685–685. 26 indexed citations
8.
Zhu, Jingjing, Ying Zhang, Xiaojie Chen, et al.. (2020). Angiopep-2 modified lipid-coated mesoporous silica nanoparticles for glioma targeting therapy overcoming BBB. Biochemical and Biophysical Research Communications. 534. 902–907. 52 indexed citations
9.
Yu, Wen-Ying, Lan Li, Fang Wu, et al.. (2020). Moslea Herba flavonoids alleviated influenza A virus-induced pulmonary endothelial barrier disruption via suppressing NOX4/NF-κB/MLCK pathway. Journal of Ethnopharmacology. 253. 112641–112641. 29 indexed citations
10.
Li, Yingchuan, Yongmei Cao, Jian Xiao, et al.. (2020). Inhibitor of apoptosis-stimulating protein of p53 inhibits ferroptosis and alleviates intestinal ischemia/reperfusion-induced acute lung injury. Cell Death and Differentiation. 27(9). 2635–2650. 400 indexed citations breakdown →
11.
Wang, Zhe, Jing Yang, Xihua Lin, et al.. (2019). A new laminopathy caused by an Arg133/Leu mutation in lamin A/C and the effects thereof on adipocyte differentiation and the transcriptome. Adipocyte. 8(1). 280–291. 4 indexed citations
12.
Liu, Feng, Kai Xu, Zhijue Xu, et al.. (2017). The small molecule luteolin inhibits N-acetyl-α-galactosaminyltransferases and reduces mucin-type O-glycosylation of amyloid precursor protein. Journal of Biological Chemistry. 292(52). 21304–21319. 38 indexed citations
13.
Xu, Shuyang, Xianmin Zhu, Hong Li, et al.. (2016). The 14th Ile residue is essential for Leptin function in regulating energy homeostasis in rat. Scientific Reports. 6(1). 28508–28508. 9 indexed citations
14.
Wu, Jie, et al.. (2016). Temperature dependence of aggregated structure of β-carotene by absorption spectral experiment and simulation. Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy. 169. 116–121. 17 indexed citations
15.
Yu, Chen-Huan, Wen-Ying Yu, Jie Fang, et al.. (2015). Mosla scabra flavonoids ameliorate the influenza A virus-induced lung injury and water transport abnormality via the inhibition of PRR and AQP signaling pathways in mice. Journal of Ethnopharmacology. 179. 146–155. 21 indexed citations
16.
Ren, Jie, Hui‐Zi Jin, Jing Yu, et al.. (2014). Novel Inhibitors of Human DOPA Decarboxylase Extracted fromEuonymus glabraRoxb.. ACS Chemical Biology. 9(4). 897–903. 16 indexed citations
17.
Eleuteri, Simona, Saviana Di Giovanni, Edward Rockenstein, et al.. (2014). Novel therapeutic strategy for neurodegeneration by blocking Aβ seeding mediated aggregation in models of Alzheimer's disease. Neurobiology of Disease. 74. 144–157. 23 indexed citations
18.
Wu, Fang. (2008). Neural stem cells: promising therapy for Alzheimer's disease. Shengming kexue. 2 indexed citations
19.
Wu, Fang & Zhirong Zhang. (2003). Determination of tetramethylpyrazine phosphate in dog plasma by RP-HPLC. Huaxi yaoxue zazhi. 17(1). 48–50. 1 indexed citations
20.
Wu, Fang. (2002). Application of High-speed Countercurrent Chromatography-Electrospray Ionization-Mass Spectrometry in Analysis of Traditional Chinese Herbs. Chemical Research in Chinese Universities. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026